Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Monocent is a U.S.-based in vitro diagnostics company that develops, manufactures, and distributes diagnostic test systems, reagents, and laboratory instruments. Its commercial portfolio spans ELISA, chemiluminescence, rapid tests, serology, immunofluorescence, PCR-related offerings, veterinary diagnostics, urinalysis, and automation platforms for laboratories and distributors. The company emphasizes infectious disease testing and has marketed a SARS-CoV-2 antigen rapid test, while also offering analyzers compatible with its immunoassay menu. Monocent appears to operate as a commercial diagnostics supplier rather than a therapeutic drug developer, with products sold internationally through distributor networks in more than 50 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Monocent.